Literature DB >> 21593154

Epithelial cell retention of transcriptionally active, P3HR-1-derived heterogeneous Epstein-Barr virus DNA with concurrent loss of parental virus.

Kazufumi Ikuta1, Mingyu Ding, Fangfang Zhang, John W Sixbey, Rona S Scott.   

Abstract

Deleted, rearranged, heterogeneous (het) Epstein-Barr virus (EBV) DNA with the distinctive capability of disrupting EBV latency has been reported in biopsy samples of EBV-associated tumors whose onset in immunocompetent hosts is characteristically preceded by an antibody response indicative of EBV reactivation. Using the EBV P3HR-1 strain, we have reproduced in long-term culture of SVK epithelial cells an unusual pattern of infection previously observed in a subset of tumor biopsy samples: the persistence of het DNA in the absence of the parental helper virus. Fluorescence in situ hybridization (FISH) of infected cell subclones indicated the retention of het DNA in an integrated form. Incorporation of an intact het DNA molecule was confirmed by PCR, using primers that framed junctions of the four rearranged EBV DNA segments comprising P3HR-1-derived het DNA. Structural analysis of EBV terminal repeats revealed a banding pattern consistent with the integration of het DNA as a concatemer. Linkage of concatemeric monomers was defined at a nucleotide level, and that junctional sequence was detected in cell-free P3HR-1 virion DNA, confirming that subgenomic het DNA was packaged into infectious particles in a concatemeric configuration. Stable integration into cells having lost the standard viral genome allowed the unambiguous designation of het DNA as the source for viral gene products potentially encoded by both. Continuous expression of the latency-to-lytic switch protein Zta and detection of the BALF4 gene product gB, known to expand the target cell range of standard virus when incorporated at augmented levels into infectious progeny, add to a presumption of het DNA-enhanced pathogenesis in diseases of EBV reactivation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593154      PMCID: PMC3147926          DOI: 10.1128/JVI.00045-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  80 in total

1.  Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus.

Authors:  Corina M Borza; Lindsey M Hutt-Fletcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

2.  Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection.

Authors:  B Neuhierl; R Feederle; W Hammerschmidt; H J Delecluse
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-30       Impact factor: 11.205

3.  Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.

Authors:  R Shinkura; N Yamamoto; C Koriyama; Y Shinmura; Y Eizuru; M Tokunaga
Journal:  J Med Virol       Date:  2000-04       Impact factor: 2.327

4.  Coreceptor restriction within the HLA-DQ locus for Epstein-Barr virus infection.

Authors:  K M Haan; R Longnecker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

5.  Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.

Authors:  Gemma L Kelly; Anne E Milner; Rosemary J Tierney; Debbie S G Croom-Carter; Markus Altmann; Wolfgang Hammerschmidt; Andrew I Bell; Alan B Rickinson
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease.

Authors:  Yan-Jun Gan; Bassem I Razzouk; Tao Su; John W Sixbey
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

7.  Mutations of Epstein-Barr virus gH that are differentially able to support fusion with B cells or epithelial cells.

Authors:  Liguo Wu; Corina M Borza; Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Epstein-Barr virus DNA XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion.

Authors:  W King; T Dambaugh; M Heller; J Dowling; E Kieff
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

9.  A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis.

Authors:  Brian G Kelly; She S Lok; Philip S Hasleton; Jim J Egan; James P Stewart
Journal:  Am J Respir Crit Care Med       Date:  2002-08-15       Impact factor: 21.405

10.  Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.

Authors:  Gemma Kelly; Andrew Bell; Alan Rickinson
Journal:  Nat Med       Date:  2002-09-03       Impact factor: 53.440

View more
  1 in total

1.  CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression-a potential differential diagnostic pitfall between PTLD and PTSMT.

Authors:  Jan-Theile Suhren; Jerome Schlué; Hans Kreipe; Kais Hussein
Journal:  Ann Hematol       Date:  2022-02-18       Impact factor: 3.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.